Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Gastric Cancer Diagnostic Procedure Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

The market size for gastric cancer diagnostic procedures has robustly expanded in the past few years. The predicted progression is from $1.44 billion in 2024 to $1.54 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Aspects contributing to the growth in the historical period include advancements in biopsy methods, a boost in research funding, development in biomarker discovery, enhanced pathological evaluation, and modifications in screening guidelines._x000D_

_x000D_

In the coming years, the market size for gastric cancer diagnostic procedures is projected to experience significant growth. The market is set to balloon to$2.06 billion by 2029, with a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this projected growth during the forecast period include an increase in point-of-care testing, the introduction of innovative biomarkers, a shift towards individualized medicine, the use of next-generation sequencing, and improved endoscopic imaging techniques. Key trends during the forecast period encompass the integration of nanotechnology, the application of big data analytics, the use of microbiota analysis, a growing focus on patient-centred approaches, and the role of telehealth in diagnostic procedures._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Gastric Cancer Diagnostic Procedure Industry?#_x000D_

The growth of the gastric cancer diagnostic procedure market is propelled by the rising occurrence of gastrointestinal illnesses. These disorders encompass diseases affecting the various parts of the digestive tract and ancillary organs such as the pancreas and liver. Gastric cancer diagnostic procedure, which includes endoscopy and biopsy, is employed to manage stomach cancer. Therefore, the escalating incidence of gastrointestinal diseases is catalyzing the growth of the gastric cancer diagnostic procedure market. For example, a research report in August 2022 from the US-based GI Associates & Endoscopy Center, a medical facility expert in gastroenterology services, involving 73,076 individuals from 33 countries showed that 40% of them were struggling with a functional gastrointestinal disorder. Thus, the rising prevalence of gastrointestinal diseases plays a significant role in the expansion of the gastric cancer diagnostic procedure market._x000D_

_x000D_

#How Is the Gastric Cancer Diagnostic Procedure Market Segmented?#_x000D_

The gastric cancer diagnostic proceduremarket covered in this report is segmented – _x000D_

_x000D_

1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue Tests; Lab Tests; In-Vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types _x000D_

2) By Symptom Type: Symptomatic; Asymptomatic_x000D_

3) By Offering Type: Instruments; Reagents And Consumables; Services_x000D_

4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid_x000D_

5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer_x000D_

_x000D_

Subsegments:_x000D_

1) By Endoscopic Procedure: Upper Endoscopy (EGD); Endoscopic Ultrasound (EUS) _x000D_

2) By Biopsy: Endoscopic Biopsy; Fine Needle Aspiration (FNA) Biopsy _x000D_

3) By Tissue Tests: Histopathology; Immunohistochemistry _x000D_

4) By Lab Tests: Blood Tests; Tumor Markers _x000D_

5) By In-Vitro Diagnostic Tests: Genetic Testing; Molecular Profiling _x000D_

6) By Imaging Tests: Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scan _x000D_

7) By Molecular Diagnostics: PCR Testing; Next-Generation Sequencing (NGS) _x000D_

8) By Multiplexing Molecular Diagnostics: Multiplex PCR; Microarray Analysis _x000D_

9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA) _x000D_

10) By Other Procedure Types: Breath Tests; Liquid Biopsies_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Gastric Cancer Diagnostic Procedure Market Growth?#_x000D_

North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Gastric Cancer Diagnostic Procedure Industry?#_x000D_

The rise in technological advancements is a noteworthy trend that is gaining traction in the gastric cancer diagnostic market. Top-tier companies in this market are leveraging the power of new technologies to maintain their market dominance. An illustration of this is Ibex Medical Analytics, an Israeli organization specializing in AI-enhanced diagnoses for health sectors, which launched Galen Gastric in June 2022. This product is the world’s inaugural AI-driven solution for detecting gastric cancer. It functions as an encompassing diagnostic tool that aids pathologists in detecting stomach cancer, H. pylori, and other vital clinical results, and it also promotes faster response times and enhances diagnostic processes._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report_x000D_

_x000D_

#How Is the Gastric Cancer Diagnostic Procedure Market Defined and What Are Its Core Parameters?#_x000D_

Gastric cancer diagnostic procedure refers to a technique of identification and medication to treat cancer cells that grow in the stomach. It is used to diagnose stomach cancer._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12038_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model